Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The complications of drug regulation

Julie Craig, MD
Meds
May 19, 2021
137 Shares
Share
Tweet
Share

When the “opioid crisis” is mentioned, most people think of heroin, prescription pills like oxycodone, or — more recently — the powerful synthetic opioid fentanyl. Fewer people would think of novel opioids like tianeptine, although an increasing number of Americans have taken this substance in the form of over-the-counter supplements like ZaZaRed or Tianna – often without knowing that the substance has opioid properties that can cause dependence and overdose. The complex pharmacology and marketing of tianeptine provide an instructive framework that can help focus and improve policies around habit-forming substances.

Tianeptine is a short-acting tricyclic antidepressant (with a half-life of 2-4 hours) that binds several receptors in the human body, including opioid receptors. Marketed for its antidepressant effects in a number of countries but never approved in the U.S., tianeptine is sold as a dietary supplement in most American states alongside the usual selection of five-hour energy drinks and male enhancement pills found at local gas stations.

Lacking formal classification in the U.S., tianeptine products fall under the 1994 Dietary Supplement Health and Education Act (DSHEA) that was intended to protect access to “natural” products like herbal remedies but ended up allowing legal sales of products with dubious origins, including manufactured substances like tianeptine. Under DSHEA, pre-market testing is not required to assess purity, efficacy or safety of substances that are marketed as supplements. In practice, weak oversight means that supplements routinely enter the American market unhindered by any regulation at all, and “natural” products routinely contain unlisted ingredients like steroids, Viagra, and sibutramine — a weight-loss drug that was withdrawn from the American market in 2010 after studies showed increased cardiovascular events with the drug.

Opioid properties of tianeptine are not disclosed on the labels of common supplements that contain this chemical, and the makers merely extol the virtues of their products with glowing promises like “alertness and an ability to focus, without the crash that you experience with caffeine.” Tianeptine is only the most recent entry into the list of unregulated substances that raise health risks.

Sudden embargoes can then complicate the management of unregulated supplements as health hazards come to light. In March of 2021, Alabama became the second state after Michigan to ban tianeptine by adding it to the state’s controlled substance list.

While well-meaning in origin, this precipitous prohibition predictably led to a stampede for remaining supplies (one individual reported spending hundreds of dollars to buy as much as possible ahead of the impending ban) and a rush to treatment for those who could no longer self-regulate in the absence of a legal supply they had come to depend on.

Unfortunately, anecdotal experience indicates that tianeptine presents spectacular difficulties when transitioning to treatment with buprenorphine, as patients report prolonged withdrawal symptoms requiring high doses of buprenorphine to consistently overcome the effects of the tianeptine.

Research is needed to better understand this observed phenomenon, as tianeptine has neither the long half-life nor the ability to store in fat cells that explains why, for example, methadone and fentanyl present challenging transitions to buprenorphine.

A better approach might have been a planned phase-out accompanied by educational campaigns to help users understand that the illness caused by abrupt tianeptine cessation is, in fact, opioid withdrawal.

Alarmingly, another unregulated supplement was marketed as a substitute for individuals detoxing off tianeptine. This product known as Phrenze Red purports to contain phenibut, a sedative more akin to gabapentinoids than opioids.

Phenibut is unlikely to help with opioid withdrawal but can cause toxicity as doses are ratcheted up to unsafe levels, resulting in a spate of hospitalizations for adverse effects and overdose. Phenibut is also likely habit-forming on its own. The substitution of one risky chemical for another is a predictable cycle largely caused by the prohibition of popular substances in the global era: when a fairly safe and well-understood drug is banned, untested substances not yet subject to prohibition rush onto the market and further endanger the dependent population. Individuals who think they are obtaining the same substance or a rough equivalent experience surprise toxicity when poorly researched novel chemicals come onto the market – an iterative process that has left us with a slew of substances like flakka in place of the mild cathinones present in traditional khat preparations from East Africa, and tianeptine in place of oxycodone.

The case of tianeptine illustrates the complications of drug regulation and prohibition in a globalized economy where novel and untested substances are the new norm. Tighter regulation of supplements, harm-reduction approaches rather than criminalization, and fact-based education on the risks and harms of novel psychoactive substances would mitigate the troubles caused by the cyclical whiplash between the untamed market of dietary supplements and the harsh consequences of drug prohibition.

Julie Craig is an addiction medicine specialist.

Image credit: Shutterstock.com

Prev

Be nice to the nurses. Respect the nurses.

May 19, 2021 Kevin 0
…
Next

How this physician created a multi-specialty ambulatory surgery clinic from scratch [PODCAST]

May 19, 2021 Kevin 0
…

Tagged as: Medications

Post navigation

< Previous Post
Be nice to the nurses. Respect the nurses.
Next Post >
How this physician created a multi-specialty ambulatory surgery clinic from scratch [PODCAST]

More by Julie Craig, MD

  • Telemedicine in the opioid crisis: a game-changer threatened by DEA regulations

    Julie Craig, MD
  • The promises and limits of a fentanyl vaccine

    Julie Craig, MD
  • We must disrupt harm

    Julie Craig, MD

Related Posts

  • A drug problem in rural Georgia

    Ashish Advani, PharmD
  • How hospitals can impact generic drug companies

    Mark Kelley, MD
  • Drug ads are a campaign against physician trust

    Judy Salz, MD
  • Crippling drug costs: the role of insurers

    Janice Boughton, MD
  • Before taking Paxlovid, consider these drug interactions

    Param Patel, PharmD
  • A missed opportunity to fix drug pricing

    Brian C. Joondeph, MD

More in Meds

  • Telemedicine in the opioid crisis: a game-changer threatened by DEA regulations

    Julie Craig, MD
  • The real cause of America’s opioid crisis: Doctors are not to blame

    Richard A. Lawhern, PhD
  • Can personalized medicine live up to its hype in health care?

    Ketan Desai, MD, PhD
  • The effects of the nationwide stimulant shortage on a private psychiatry practice

    Christine Tran-Boynes, DO
  • Why North American medical cannabis can’t compete globally

    Michael Sassano
  • How were we duped and what can we do about the opioid overdose crisis?

    Ronald A. Zent, MD
  • Most Popular

  • Past Week

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • The struggle to fill emergency medicine residency spots: Exploring the factors behind the unfilled match

      Katrina Gipson, MD, MPH | Physician
    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • Deaths of despair: an urgent call for a collective response to the crisis in U.S. life expectancy

      Mohammed Umer Waris, MD | Policy
    • Beyond the disease: the power of empathy in health care

      Nana Dadzie Ghansah, MD | Physician
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
  • Recent Posts

    • The power of self-appreciation: Why physicians need to start acknowledging their own contributions

      Wendy Schofer, MD | Physician
    • The endless waves of chronic illness

      Michele Luckenbaugh | Conditions
    • Skydiving and surgery: How one doctor translates high-stress training to saving lives

      Alexandra Kharazi, MD | Physician
    • Telemedicine in the opioid crisis: a game-changer threatened by DEA regulations

      Julie Craig, MD | Meds
    • How this doctor found her passion in ballroom dancing [PODCAST]

      The Podcast by KevinMD | Podcast
    • Surviving and thriving after life’s most difficult moments

      Rebecca Fogg, MBA | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Make the Diagnosis: This Bump on His Nose is a Tricky Diagnosis
  • CRT Regimen Boosts Complete Response Rate in Unresectable Vulvar Cancer
  • Fla. Doc Charged With Murder; McConnell Exits Rehab Facility; BPA on Store Receipts
  • FDA Faults Next-Gen Olympus Duodenoscopes
  • CDK4/6 Inhibition Active in Recurrent Low-Grade Serous Ovarian Cancer

Meeting Coverage

  • Ankle Sprain Physical Therapy Doesn't Shift the Pain Elsewhere
  • Use of EMR Directive Tied to Reduced Opioid Prescribing After Spine Surgery
  • CRT Regimen Boosts Complete Response Rate in Unresectable Vulvar Cancer
  • CDK4/6 Inhibition Active in Recurrent Low-Grade Serous Ovarian Cancer
  • Switch to IL-23 Blocker Yields Deep Responses in Recalcitrant Plaque Psoriasis
  • Most Popular

  • Past Week

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • The struggle to fill emergency medicine residency spots: Exploring the factors behind the unfilled match

      Katrina Gipson, MD, MPH | Physician
    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • Deaths of despair: an urgent call for a collective response to the crisis in U.S. life expectancy

      Mohammed Umer Waris, MD | Policy
    • Beyond the disease: the power of empathy in health care

      Nana Dadzie Ghansah, MD | Physician
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
  • Recent Posts

    • The power of self-appreciation: Why physicians need to start acknowledging their own contributions

      Wendy Schofer, MD | Physician
    • The endless waves of chronic illness

      Michele Luckenbaugh | Conditions
    • Skydiving and surgery: How one doctor translates high-stress training to saving lives

      Alexandra Kharazi, MD | Physician
    • Telemedicine in the opioid crisis: a game-changer threatened by DEA regulations

      Julie Craig, MD | Meds
    • How this doctor found her passion in ballroom dancing [PODCAST]

      The Podcast by KevinMD | Podcast
    • Surviving and thriving after life’s most difficult moments

      Rebecca Fogg, MBA | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today iMedicalApps
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...